Sign in
CLDI Stock Price, Chart, Stats & News
Calidi Biotherapeutics, Inc.
Save
Calidi Biotherapeutics, Inc. (CLDI) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
CLDI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.10% |
ROA | -225.21% |
ROE | -411.66% |
D/E | 0.52x |
Interest coverage ratio | -58.24x |
CLDI valuation
P/E | – |
P/S | – |
P/B | 0.35x |
P/CF | -0.06x |
P/FCF | -0.09x |
P/OCF | -0.06x |
PEG | -0.00x |
EV multiple | -0.31x |
About
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions, including aggressive brain tumors (high-grade gliomas) and other solid malignancies.
Similar securities
Based on sector and market capitalization
Report issue